Cover of: New developments in breast cancer research | Read Online

New developments in breast cancer research

  • 934 Want to read
  • ·
  • 18 Currently reading

Published by Nova Science Publishers in New York .
Written in English


  • Breast -- Cancer -- Research.,
  • Breast Neoplasms.,
  • Research -- trends.

Book details:

Edition Notes

Includes bibliographical references and index.

StatementAndrew P. Yao, editor.
ContributionsYao, Andrew P.
LC ClassificationsRC280.B8 N474 2006
The Physical Object
Paginationp. ;
ID Numbers
Open LibraryOL3413594M
ISBN 101594548099
LC Control Number2005029733

Download New developments in breast cancer research


Breast Cancer Treatment. The mainstays of breast cancer treatment are surgery, radiation, chemotherapy, hormone therapy, and targeted therapy. But scientists continue to study novel treatments and drugs, along with new combinations of existing treatments. NCI Experts Discuss Challenges in Breast Cancer Research. This is the fourth book in a series dealing with breast cancer. Volumes were concerned with treatment, experimental biology, and a number of varied timely topics. The present volume continues to review the breast cancer field in the broadest sense. The first chapter addresses the question of selecting appropriate chemotherapy for the : Paperback. Her message is powerful. Experience it for yourself. Breast cancer patients having surgery at the Johns Hopkins Avon Foundation Breast Center receive a free copy of this book in their “comfort bag” which is given to them the day of their surgery. Researchers are now exploring a number of potential markers of breast cancer in blood, including proteins made by genes linked to cancer (oncogenes), growth factors, antibodies associated with tumors, and markers of blood vessel development, which is common in : Margie Patlak, Sharyl J. Nass, I. Craig Henderson, Joyce C. Lashof.

  At the AACR Annual Meeting, BCRF investigator and outgoing president of AACR Dr. Elizabeth Jaffee chaired a session where breast cancer experts discussed the landscape of treatments for breast cancer subtypes and emerging therapies in clinical trials or in development. Estrogen receptor-positive (ER) breast cancer. Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer.   The Translational Breast Cancer Program is a newly-established research group within the ONJ Centre, headed by Professor Anderson, whose members include Dr Yeo. Its focus is on identifying the genes that control the spread of breast cancer, a process call metastasis. Using this knowledge, they are working on developing new and more effective.   Breast cancer is in many ways ahead of other solid tumors in terms of targeted therapies. But one of the most exciting recent advances in cancer research has largely passed by breast cancer. Immunotherapy has had tremendous success in melanoma, kidney cancer, lung cancer and prostate cancer. But no immunotherapy drugs have been approved for.

A new study conducted primarily in mice suggests that chemotherapy given before surgery for breast cancer can cause changes in cells in and around the tumor that are tied to an increased risk of the cancer spreading to other areas of the body. This volume provides resources, ideas, and bench manuals for the study of breast cancer. This book is divided into five sections: methods used in clinical laboratory for diagnosis (Detection of Molecular Markers of Breast Cancer); methods used in both clinical and research laboratories for testing genetic alterations (Genetic Detection of Breast Cancer) and (Isolation of Breast Cancer Cells. (less than 1 per cent of cases [2]), breast cancer can occur in men, but it is not included here. 1. Trends, incidence, and survival Breast cancer is the most common cancer in women in high-, middle- and low-income countries.[3] Age-adjusted rates of breast cancer in women are increasing in most.   A report on the association of estrogen replacement therapy with an increased risk of breast cancer led to a large drop in prescriptions for the drugs used in such therapy; a coincident drop in the incidence of breast cancer tumors, especially estrogen-positive tumors, which apparently could not be accounted for by other causes, strongly.